Background: Plasma lipases and lipid transfer proteins are involved in the generation and speciation of high density lipoproteins. In this study we have examined the influence of plasma lipases and lipid transfer protein activities on the transfer of free cholesterol (FC) and phospholipids (PL) from lipid emulsion to human, rat and mouse lipoproteins. The effect of the lipases was verified by incubation of labeled (3H-FC, 14C-PL) triglyceride rich emulsion with human plasma (control, post-heparin and post-heparin plus lipase inhibitor), rat plasma (control and post-heparin) and by the injection of the labeled lipid emulsion into control and heparinized functionally hepatectomized rats. Results: In vitro, the lipase enriched plasma stimulated significantly the transfer of 14C-PL from emulsion to high density lipoprotein (p<0.001) but did not modify the transfer of 3H-FC. In hepatectomized rats, heparin stimulation of intravascular lipolysis increased the plasma removal of 14C-PL and the amount of 14C-PL found in the low density lipoprotein density fraction but not in the high density lipoprotein density fraction. The in vitro and in vivo experiments showed that free cholesterol and phospholipids were transferred from lipid emulsion to plasma lipoproteins independently from each other. The incubation of human plasma, control and control plus monoclonal antibody anti-cholesteryl ester transfer protein (CETP), with 14C-PL emulsion showed that CETP increases 14C-PL transfer to human HDL, since its partial inhibition by the anti-CETP antibody reduced significantly the 14C-PL transfer (p<0.05). However, comparing the nontransgenic (no CETP activity) with the CETP transgenic mouse plasma, no effect of CETP on the 14C-PL distribution in mice lipoproteins was observed. Conclusions: It is concluded that: 1-intravascular lipases stimulate phospholipid transfer protein mediated phospholipid transfer, but not free cholesterol, from triglyceride rich particles to human high density lipoproteins and rat low density lipoproteins and high density lipoproteins; 2-free cholesterol and phospholipids are transferred from triglyceride rich particles to plasma lipoproteins by distinct mechanisms, and 3 - CETP also contributes to phospholipid transfer activity in human plasma but not in transgenic mice plasma, a species which has high levels of the specific phospholipid transfer protein activity.2 19Backer, G., Bacquer, D., Konitzer, M., Epidemiological aspects of high density lipoprotein cholesterol (1998) Atherosclerosis, 137, pp. S1-S6Stein, O., Stein, Y., Atheroprotective mechanisms of HDL (1999) Atherosclerosis, 144, pp. 285-301Tall, A.R., Plasma lipid transfer proteins (1995) Annu Rev Biochem, 64, pp. 235-257Hesler, B., Tall, A.R., Swenson, T.L., Weech, P.K., Marcel, Y.L., Milne, R.W., Monoclonal antibody to the Mr 74000 cholesterol ester transfer protein neutralize all of the cholesterol ester and triglyceride transfer activities in human plasma (1988) J Biol Chem, 263, pp. 5020-5023Swenson, T.L., Brocia, R.W., Tall, A.R., Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids (1988) J Biol Chem, 263, pp. 5150-5157Lagrost, L., Athias, A., Gambert, P., Lallemant, C., Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein (1994) J Lipid Res, 35, pp. 825-835Tato, F., Vega, G.L., Grundy, S.M., Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients (1997) Arterioscler Thromb Vasc Biol, 17, pp. 56-63Tall, A.R., Forester, L.R., Bongiovanni, G.L., Facilitation of phosphatidylcholine transfer into HDL lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma (1983) J Lipid Res, 24, pp. 277-289Albers, J.J., Tollefson, J.H., Chen, C.H., Steinmetz, A., Isolation and characterization of human plasma lipid transfer proteins (1984) Arteriosclerosis, 4, pp. 49-58Guyard-Dangremont, V., Desrumaux, C., Gambert, P., Lallemant, C., Lagrost, L., Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility (1998) Comp Biochem Physiol Biochem Mol Biol, 120, pp. 517-525Tall, A.R., Krumholz, S., Olivecrona, T., Deckelbaum, R.J., Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between VLDL and HDL lipoproteins during lipolysis (1985) J Lipid Res, 26, pp. 842-851Nishida, H.I., Nishida, T., Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins (1997) J Biol Chem, 272, pp. 6959-6964Lagrost, L., Desrumaux, C., Masson, D., Deckert, V., Gambert, P., Structure and function of the plasma phospholipid transfer protein (1998) Curr Opin Lipidol, 9, pp. 203-209Albers, J.J., Tu, A.Y., Paigen, B., Chen, H., Cheung, M.C., Marcovina, S.M., Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio (1996) Int J Clin Lab Res, 26, pp. 262-267Foger, B., Santamarina-Fojo, S., Shamburek, R.D., Parrot, C.L., Talley, G.D., Brewer Jr., H.B., Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL (1997) J Biol Chem, 272, pp. 27393-27400Redgrave, T.G., Small, D.M., Quantitation of the transfer of surface phospholipid of chylomicrons to the HDL lipoprotein fraction during the catabolism of chylomicrons in the rat (1979) J Clin Invest, 64, pp. 162-171Tall, A.R., Green, P.H., Glickman, R.M., Riley, J.W., Metabolic fate of chylomicron phospholipids and apoproteins in the rat (1979) J Clin Invest, 64, pp. 977-989Tall, A.R., Blum, C.B., Forester, G.P., Nelson, C.A., Changes in the distribution and composition of plasma HDL liproteins after ingestion of fat (1982) J Biol Chem, 257, pp. 198-207Groot, H., Scheek, L.M., Effects of fat ingestion on HDL profiles in human sera (1984) J Lipid Res, 25, pp. 684-692Brunzell, J.D., Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome (1995) Metabolic & Molecular Bases of Inherited Disease, pp. 1913-1932. , Scriver, CR, Beaudet, AL, Sly, WS, ed, McGraw-Hill Inc, New York, 7th edBijvoet, S., Gagne, S.E., Moorjani, S., Gagne, C., Henderson, H.E., Fruchart, J.C., Dallongeville, J., Hayden, M.R., Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency (1996) J Lipid Res, 37, pp. 640-650Kuusi, T., Ehnholm, C., Viikari, J., Harkonen, R., Vartiainen, E., Puska, P., Taskinen, M.-R., Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia (1989) J Lipid Res, 30, pp. 1117-1126Liu, S., Jirik, F.R., LeBoeuf, R.C., Henderson, H., Castellani, L.W., Lusis, A.J., Ma, Y., Kirk, E., Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase (1994) J Biol Chem, 269, pp. 11417-11424Weinstock, P.H., Bisgaier, C.L., Aalto-Setala, K., Radner, H., Ramakrishnan, R., Levak-Frank, S., Essenburg, A.D., Breslow, J.L., Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes (1995) J Clin Invest, 96, pp. 2555-2568Applebaum-Bowden, D., Kobayashi, J., Kashyap, V.S., Brown, D.R., Berard, A., Meyn, S., Parrott, C., Santamarina-Fojo, S., Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium (1996) J Clin Invest, 97, pp. 799-805Gillett, M.P., Vieira, E.M., Dimenstein, R., The phospholipase activities present in preheparin mouse plasma are inhibited by antiserum to hepatic lipase (1993) Int J Biochem, 25, pp. 449-453Ha, Y.C., Barter, P.J., Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species (1982) Comp Biochem Physiol B, 71, pp. 265-269Clee, S.M., Zhang, H., Bissada, N., Miao, L., Ehrenborg, E., Benlian, P., Shen, G.X., Hayden, M.R., Relationship between lipoprotein lipase and HDL lipoprotein cholesterol in mice: Modulation by cholesteryl ester transfer protein and dietary status (1997) J Lipid Res, 38, pp. 2079-2089Oliveira, H.C.F., Hirata, M.H., Redgrave, T.G., Maranhão, R.C., Competition between chylomicrons and their remnants for plasma removal: A study with artificial emulsion models of chylomicrons (1988) Biochim Biophys Acta, 958, pp. 211-217Nakandakare, E.R., Lottenberg, S.A., Oliveira, H.C.F., Bertolami, M.C., Vasconcelos, K.S., Sperotto, G., Quintão, E.C., Simultaneous measurements of chylomicron lipolysis and remnant removal using a doubly labeled artificial lipid emulsion: Studies in normolipidemic and hyperlipidemic subjects (1994) J Lipid Res, 35, pp. 143-152Jiao, S., Cole, T.G., Kitchens, R.T., Pfleger, B., Schonfeld, G., Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography (1990) Metabolism, 39, pp. 155-160Ehnholm, C., Kuusi, T., Preparation, characterization and measurement of hepatic lipase (1986) Methods Enzymol, 129, pp. 716-738Oliveira, H.C.F., Quintão, E.C., 'In vitro' cholesteryl ester bidirectional flow between high-density lipoproteins and triglyceride-rich emulsions: Effects of particle concentration and composition, cholesteryl ester transfer activity and oleic acid (1996) J Biochem Biophys Methods, 32, pp. 45-57Huff, M.W., Miller, D.B., Wolf, B.M., Connelly, P.W., Sawyez, C.G., Uptake of hypertriglyceridemic VLDL and their remnants by HepG2 cells: The role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans (1997) J Lipid Res, 38, pp. 1318-1333Marques-Vidal, P., Jauhiainen, M., Metso, J., Ehnholm, C., Transformation of HDL2 particles by hepatic lipase and phospholipid transfer protein (1997) Atherosclerosis, 133, pp. 87-96Murdoch, S.J., Breckenridge, W.C., Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL (1996) Biochim Biophys Acta, 1303, pp. 222-232Murdoch, S.J., Breckenridge, W.C., Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL (1995) Atherosclerosis, 118, pp. 193-212Patsch, J.R., Gotto Jr., A.M., Olivercrona, T., Eisenberg, S., Formation of HDL2-like particles during lipolysis of VLDL in vitro (1978) Proc Natl Acad Sci USA, 75, pp. 4519-4523Gillett, M.P., Costa, E.M., Owen, J.S., The phospholipase activities present in preheparin mouse plasma are inhibited by antiserum to hepatic lipase (1980) Biochim Biophys Acta, 617, pp. 237-244Peterson, J., Bengtsson-Olivecrona, G., Olivecrona, T., Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin (1986) Biochim Biophys Acta, 87, pp. 865-870O'Meara, N.M., Cabana, V.G., Lukens, J.R., Loharikar, B., Forte, T.M., Polonsky, K.S., Getz, G.S., Heparin-induced lipolysis in hypertriglyceridemic subjects results in the formation of atypical HDL particle (1994) J Lipid Res, 35, pp. 2178-2190